Ethyl acetate extracts of the phytopathogenic fungi Diplodia maydis and Sclerotium rolfsii presented antibacterial activity against multidrug resistant bacteria isolated from patients in the University Hospital (HUOP-Unioeste, Brazil).
Phytopathology Department of the Universidade Estadual do Oeste do Paraná, PR, Brazil. The production was carried out by inoculating 10 8 spore/mL in BDA medium at 28ºC in a shaking incubator at 150 rpm for 168h. The cultures were filtered and submitted to the process of liquid-liquid partition furnishing the ethyl acetate extract that were c oncentrated by rotaevaporation. For the antibacterial assay 2.0 µg/mL of the extracts were applied to pre-coated TLC plates, without elution of the samples. The inoculum was prepared by culturing each organism on tryptone soya agar medium (TSA, Oxoid) at 37ºC to turbidity equivalent to McFarland 0.5 standard (1.5 x 10 8 CFU/mL). One microliter of each diluted inoculum (10 4 -10 6 CFU) was applied onto Mueller Hinton Agar medium (MHA-DIFCO), and distributed over TLC plates (2x4 cm). After solidification of the media, the TLC plates were incubated overnight at 37ºC. Ciclopirox olamine was used as positive control. The experiments were repeated twice. Biotechnology consists in the use of cellular systems for the development of processes and products holding economical and social interest. Within these systems, the fungi are of great biotechnological interest in fermentative processes that culminate in the production of secondary metabolites that are important for search of new antibiotics. The discovery and development of antibiotics was one of the most significant advances in medicine in the 20 th century. Nevertheless, many antibacterial agents that were used to treat a variety of human infectious diseases are now ineffective. Therefore, to ensure that effective drugs will be available in the future, it is necessary to improve the antibacterial use patterns and to devise strategies to identify new antibiotics through previously unexplored targets (5). As part of an ongoing research for biological active secondary metabolites from phytopathogenic fungi (1,2) we have detected antibacterial activity in fermentation ethyl acetate extracts of Diplodia maydis and Sclerotium rolfsii fungi that were isolated from culture of mays and soya, respectively. They were evaluated against twelve Gram-negative bacteria and four Gram-positive bacteria using the bioautography assay (3, 4) . The fungi were obtained at the The results showed a variable effect of fungi extracts on the microorganisms. The fungus S. rolfsii was more active showing greatest values of zone of inhibition than D. maydis and antibiotic used as positive control. Screening for antibacterial activity of phythopatogenic fungi has not been described yet. This study demonstrated that ethyl acetate extracts of D. maydis and S. rolfsii fungi have a broader spectrum of inhibiting action to growth of all the bacteria tested showing that the fungi produced secondary metabolites that may be used as antibiotic agents or as prototypes of them. Results indicate that the potential of these microorganisms to produce antibacterial compounds is great and must be better explored, stimulating us to investigate antibacterial chemical constituents that will be reported in due course. 
Bacteria Antibiotics
Acinetobacter baumannii amikacin, ampicillin, aztreonam, cefotaxime, ceftazidime, cefepime, ciprofloxacin, chloranphenicol, gentamicin, imipenem and sulfazotrin.
Enterococcus cloacae ampicillin, cephalothin, cefotaxime, chloranphenicol, gentamicin and sulfazotrin.
Klebsiella pneumoniae nalidixic acid, pipemidine acid, ampicillin, cephalothin, cefepime, ceftazidime, gentamicin, nitrofurantoin and sulfazotrin.
Proteus mirabilis nalidixic acid, pipemidine acid, ampicillin, cephalothin, cefepime, ceotaxime, cefoxitin, ceftazidime, nitrofurantoin and sulfazotrin.
Staphylococcus aureus azithromycin, ciprofloxacin, clindamycin, chloranphenicol, erythromycin, oxacillin, penicillin and sulfazotrin.
Staphylococcus coagulase negative azithromycin, ciprofloxacin, clindamycin, chloranphenicol, erythromycin, oxacillin, penicillin, sulfazotrin, tetracycline and vancomycin. 
